TrialMedical oncology (Northwood, London, England)2022

Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833).

Isacco Desideri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.